Market Research Reports

All Reports Home

Categories

Countries

Consumer Healthcare Reports

Invasive Ductal Carcinoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy), By Type (Hormone Receptor, HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), By Region and Competition, 2019-2029F

Rising incidence of breast cancer and advancements in diagnostic Technologies are factors driving the Global Invasive Ductal Carcinoma Treatment market in the Read More

Japan Sarcoma Drugs Market, By Treatment Type (Chemotherapy, Targeted Therapy, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2020-2030F

Advancements in Molecular and Genetic Research and Growing Incidence of Sarcoma Cases are factors driving the Japan Sarcoma Drugs market in the forecast period Read More

Japan Infectious Disease Drugs Market, By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Other), By Treatment (Antibacterial, Antiviral, Antiparasitic, Other), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Incidence of Infectious Diseases and Technological Advancements in Drug Development are factors driving the Japan Infectious Disease Drugs market in Read More

Japan Precision Medicine Market, By Application (Diagnostics, Therapeutics), By End User (Home Care, Hospitals, Clinical Laboratories, Others), By Region, Competition Forecast & Opportunities, 2020-2030F

Advances in Genomic and Molecular Technologies and Increasing Prevalence of Chronic and Complex Diseases are factors driving the Japan Precision Medicine market Read More

Japan Prostate Cancer Drugs Market, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Others), By End User (Clinics, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Incidence of Prostate Cancer and Advancements in Treatment Technologies are factors driving the Japan Prostate Cancer Drugs market in the forecast period Read More

Japan Respiratory Drugs Market, By Type (Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis), By Application (Hospitals, Ambulatory Care, Homecare, Pharmacies), By Age Group (Pediatric, Adult), By Distribution Channel (Prescription, Over-the-Counter), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Incidence of Respiratory Diseases and Advancements in Drug Development are factors driving the Japan Respiratory Drugs market in the forecast period Read More

Japan Renal Cancer Drugs Market, By Type (Renal Cell Carcinoma (RCC), Papillary Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Transitional Cell Carcinoma, Wilms Tumor (Nephroblastoma), Renal Sarcoma, Angiomyolipoma, Oncocytoma, Others), By Drug Class (Monoclonal Antibodies, mTOR Inhibitors, Immune Checkpoint Inhibitor, Combined Therapies, Interleukin-2, Alpha-Interferon, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Incidence and Prevalence of Renal Cancer and Increased Investment in Research and Development (R&D) are factors driving the Japan Renal Cancer Drugs Read More

Japan Pulmonary Arterial Hypertension Drugs Market, By Drug Class (Endothelin Receptor Antagonists (ERAs), Phosphodiesterase-5 (PDE-5) Inhibitors, Soluble Guanylate Cyclase (sGC) Stimulators, Prostacyclin Analogues, Calcium Channel Blockers, Others), By Route of Administration (Oral, Inhalation, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in Medical Research and Drug Development and Increasing Prevalence of Pulmonary Arterial Hypertension (PAH) are factors driving the Japan Pulmonary Read More

Japan Rheumatoid Arthritis Drugs Market, By Molecule Type (Pharmaceuticals, Biopharmaceuticals), By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Analgesics, Other) By Distribution Channel (Prescription, Over-the-counter (OTC)), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Incidence and Prevalence of Rheumatoid Arthritis (RA) and Advancements in Drug Development and Innovation are factors driving the Japan Rheumatoid Read More

Japan Alzheimer’s Therapeutics Market, By Product (Cholinesterase inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End User (Hospital Pharmacy, Retail Pharmacy, E-commerce), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Prevalence of Alzheimer’s Disease and Advances in Diagnostic Technologies are factors driving the Japan Alzheimer’s Therapeutics market in the forecast Read More

Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Healthcare Costs and Demand for Affordable Therapies and Technological Advancements in Biomanufacturing are factors driving the Japan Biosimilars market Read More

Japan Blood Plasma Market, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others), By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Others), By End User (Hospitals, Clinics, Others), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Prevalence of Blood Disorders and Advancements in Plasma-Based Therapies are factors driving the Japan Blood Plasma market in the forecast period Read More

Japan Burn Care Market, By Burn Type (Thermal Burn, Electrical Burn, Chemical Burn, Radiation Burn, Friction Burn, Others), By Product Type (Advanced Burn Care, Biologics, Traditional Burn Care, Other), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals, Specialty Clinics, Others), By Distribution Channel (Online, Offline), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Incidence of Burn Injuries and Increased Awareness and Preventive Measures are factors driving the Japan Burn Care market in the forecast period 2026-2030.Read More

Japan Cancer Supportive Care Market, By Therapeutics Class (G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), Anti-emetics, Bisphosphonates, Opioids, NSAIDs, Others), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Cancer Incidence and Rising Awareness and Demand for Quality of Life Improvements are factors driving the Japan Cancer Supportive Care market in the Read More

Mass Spectrometry and Chromatography in Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Sample Preparation, Mass Spectrometry, Chromatography), By Application Type (Therapeutic Drug Monitoring, Vitamins, Hormones, Methylmalonic Acid, Immunosuppressants, Others), By Sample Type (Blood, Urine, Serum, Plasma, Saliva), By Testing Type (Laboratory-Developed Tests, Commercial Assays), By Region and Competition, 2019-2029F

Rising incidence of chronic diseases and technological advancements are factors driving the Global Mass Spectrometry and Chromatography in Diagnostics market in Read More

ELISpot and FluoroSpot Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Assay Kits, Analyzers, Ancillary Products), By Application (Diagnostic, Research), By End user (Hospitals & Clinics, Research Institutes, Biopharmaceutical Companies and CROs), By Region and Competition, 2019-2029F

Increasing prevalence of infectious diseases and rising research and development activities are factors driving the Global ELISpot and FluoroSpot Assay Market in Read More

Gynecomastia Procedures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Age Group (18-40, Above 40), By Procedure Type (Liposuction, Excision), By End-Use (Hospitals, Cosmetic Surgery Center), By Region & Competition, 2019-2029F

Rising prevalence of hormonal imbalances and obesity are expected to drive the Global Gynecomastia Procedures Market in the forecast period 2025-2029.Read More

Picosecond Lasers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (ND: YAG, Alexandrite), By Application (Tattoo Removal, Pigmented Lesions, Skin Rejuvenation, Melasma, Others), By End-use (Dermatology Clinics, Med Spas & Aesthetic Centers, Others), By Region & Competition, 2019-2029F

Rising awareness of aesthetic treatment are expected to drive the Global Picosecond Lasers Market in the forecast period 2025-2029.Read More

Europe Pre-Workout Supplements Market By Type (Powder, Capsule/ Tablet, Drinks, Other), By Distribution Channel (Online, Offline), By Country, Competition, Forecast, and Opportunities, 2019-2029F

Increasing awareness of the benefits of regular exercise are expected to drive the Europe Pre-Workout Supplements market in the forecast period 2025-2029F.Read More

Europe Nucleic Acid Sample Preparation Market By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology and Others), By Application (Genomics, Proteomics and Others), By Country, Competition, Forecast and Opportunities, 2019-2029F

Growing prevalence of chronic diseases and increasing demand for molecular diagnostics are factors driving the Europe Nucleic Acid Sample Preparation Market in Read More

Prev    Page 4 of 88 Next